We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (20 December 2024) granted a conditional marketing authorisation for the medicine givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD).
Lord Willetts appointed as Chair of the Regulatory Innovation Office
Results for the Vivaldi study for antibody and cellular immune responses to coronavirus (COVID-19) in approximately 340 care homes.
Report setting out the results of a study of 124 staff and residents in 19 long term care homes who have received an mRNA booster following 2 doses of either Pfizer or AstraZeneca between May and November 2021
Report setting out the results of a study of 202 staff and 286 residents in care homes undertaken between December 2020 and June 2021.
Information for healthcare professionals on the clinical investigation and management of COVID-19 vaccine induced thrombosis and thrombocytopenia (VITT).
This study provides a summary of antigen testing in all care homes for those over 65 years old in England and survey results of managers of those homes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).